Avoiding Inadequate Intrapartum Antibiotic Prophylaxis for Group B Streptococci

Obstetrics and Gynecology

Volumn 128, Issue 3, 2016, Pages 598-603

  Bienenfeld, Sarah ^a   Rodriguez Riesco, Laura G ^a   Heyborne, Kent D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CLINDAMYCIN; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; COHORT ANALYSIS; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; LABOR; MAJOR CLINICAL STUDY; NEWBORN; PENICILLIN ALLERGY; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; TOTAL QUALITY MANAGEMENT; VAGINAL DELIVERY; FAILURE TO RESCUE (HEALTH CARE); INFANT, NEWBORN, DISEASES; MICROBIOLOGY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PROCEDURES; PUBLIC HEALTH SERVICE; STANDARDS; STATISTICS AND NUMERICAL DATA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TRANSMISSION; UNITED STATES; VERTICAL TRANSMISSION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FAILURE TO RESCUE, HEALTH CARE; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LABOR, OBSTETRIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 84981170222     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001564     Document Type: Article

References (21)

1. American College of Obstetrics and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion No. 173. Washington, DC; ACOG: 1996.
2. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996;45:1-24.
3. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057-64.
4. Centers for Disease Control and Prevention (CDC). Trends in perinatal group B streptococcal disease-United States, 2000-2006. MMWR Morb Mortal Wkly Rep 2009;58:109-12.
5. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056-65.
6. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
7. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease revised guidelines from CDC. MMWR Recomm Rep 2010;59:1-36.
8. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-32. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5910a1. htm?s-cid5rr5910a1-w. Retrieved May 17, 2016.
9. Prevention of early-onset group B streptococcal disease in newborns. Committee Opinion No. 485. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:1019-27.
10. Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001; 184:1204-10.
11. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
12. Pulver LS, Hopfenbeck MM, Young PC, Stoddard GJ, Korgenski K, Daly J, et al. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis. J Perinatol 2009;29:20-5.
13. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240-6.
14. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360: 2626-36.
15. GraphPad QuickCalcs. Confidence interval of a proportion or count. Available at: http://graphpad.com/quickcalcs/ConfInterval1. cfm. Retrieved May 17, 2016.
16. Centers for Disease Control and Prevention (CDC). Announcements: smartphone application available for preventing group B streptococcus infections. MMWR Recomm Rep 2014; 63:162.
17. Goins WP, Talbot TR, Schaffner W, Edwards KM, Craig AS, Schrag SJ, et al. Adherence to perinatal group B streptococcal prevention guidelines. Obstet Gynecol 2010;115:1217-24.
18. Paccione KA, Wiesenfeld HC. Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients. Infect Dis Obstet Gynecol 2013;2013:917304.
19. Critchfield AS, Lievense SP, Raker CA, Matteson KA. Group B streptococcus prophylaxis in patients who report a penicillin allergy: a follow-up study. Am J Obstet Gynecol 2011;204: 150.e1-8.
20. Briody VA, Albright CM, Has P, Hughes BL. Use of Cefazolin for Group B Streptococci Prophylaxis in Women Reporting a Penicillin Allergy Without Anaphylaxis. Obstet Gynecol 2016;127:577-83.
21. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345:804-9.